CYBB and myeloid sarcoma: Conversely, in CD4+ cells, we noticed the opposite situation, with a 1.75-fold significant CYBB increased expression in RR-MS females patients (p = 0.014) and a 0.74-fold decrease (not significant) in MS male cases compared to healthy controls.